A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

NCT05140811 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

126

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: IMM01
DRUG: Azacitidine

Sponsor

ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Collaborators

[object Object]